Light‐Switched Mesenchymal Stem Cells for In Situ Exosome Amplification in Craniofacial Bone Defect Reconstruction
Advanced Science · 2026
DOI: 10.1002/advs.75519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Tingting Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Exosomes, Bone Regeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Mesenchymal stem cell (MSC)‐based therapies hold great promise for tissue regeneration, yet precise spatiotemporal regulation of their bioactivity remains challenging. Here, we report a light‐switchable MSC system (MSC‐UCNPs) enabled by intracellular upconversion nanoparticles (UCNPs), which allowed remote control of exosome biogenesis and regenerative function. Upon 980 nm near‐infrared irradiation, intracellular UCNPs emitted localized 365 nm ultraviolet light without compromising MSC viability. The generated UVA stimulus activated the ROS/HEXB/LAMP1 signaling cascade, suppressing lysosome–multivesicular body fusion and thereby markedly enhancing exosome production (increased to 2.7‐fold). The MSC‐derived exosomes exerted autocrine effects to promote MSC proliferation and osteogenic differentiation, while also facilitating osteoblast maturation via activating the Wnt/β‐catenin pathway. To facilitate in vivo application, an injectable hydrogel composed of sodium alginate, calcium alginate, and hyaluronic acid was constructed through electrostatic interactions for the localized delivery of MSC‐UCNPs. Positron emission tomography–computed tomography (PET‐CT) imaging confirmed the in vivo light‐switchable behavior of MSC‐UCNPs, allowing on‐demand enhancement of in situ exosome release. Benefiting from the synergistic regenerative effects of MSCs and their exosomes, this light‐responsive MSC platform achieved robust cranial bone regeneration with a 3.2‐fold greater bone volume fraction compared to the control group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Hubei Province Clinical Research Center For Precision Medicine For Critical Illness, Wuhan, Hubei, China.
- Hubei Key Laboratory of Natural Active Polysaccharides, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, T., Liu, Y., Wang, S., Bai, X., Zhang, L., Liu, Y., Fu, Z., & Shi, C. (2026). Light‐Switched Mesenchymal Stem Cells for In Situ Exosome Amplification in Craniofacial Bone Defect Reconstruction. Advanced Science. https://doi.org/10.1002/advs.75519
Vancouver
Wu T, Liu Y, Wang S, Bai X, Zhang L, Liu Y, et al. Light‐Switched Mesenchymal Stem Cells for In Situ Exosome Amplification in Craniofacial Bone Defect Reconstruction. Advanced Science. 2026. doi:10.1002/advs.75519
BibTeX
@article{Wu2026,
author = {Wu, Tingting and Liu, Yajing and Wang, Shuman and Bai, Xiaoming and Zhang, Luyun and Liu, Yuwei and Fu, Zhiwen and Shi, Chen},
title = {Light‐Switched Mesenchymal Stem Cells for In Situ Exosome Amplification in Craniofacial Bone Defect Reconstruction},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.75519}
}
EUVIMED